icon-folder.gif   Conference Reports for NATAP  
 
  53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO
Back grey_arrow_rt.gif
 
 
 
STaR: Virologic Outcomes and Safety in ART-Na´ve Adult Females for Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF Compared to Efavirenz/Emtricitabine/Tenofovir DF at Week 48
 
 
  Reported by Jules Levin
53rd Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC)September 10-13, 2013
Denver, CO, USA
 
C Brinson1, S Segal-Maurer2, I Brar3, C Creticos4, C McDonald5, B Wade6, R Ebrahimi7, D Porter7, S De-Oertel7, T Fralich7, J DeMorin7, K Khorana7 1Central Texas Clinical Research, Austin, TX, USA; 2New York Hospital Queens, Flushing, NY, USA; 3Henry Ford Hospital, Detroit, MI, USA; 4NorthShore University Health System, Chicago, IL, USA; 5Tarrant County Infectious Disease, Fort Worth, TX, USA; 6Center for Prevention/Treatment, Pensacola, FL, USA; 7Gilead Sciences, Foster City, CA, USA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif

ICAAC10.gif

ICAAC11.gif

ICAAC12.gif